Sanofi Global Health launches nonprofit Impact® brand for 30 medicines in low-income countries

The Impact® brand, which includes insulin, glibenclamide and oxaliplatin amonst others, will enable the secure distribution of 30 Sanofi medicines in 40 lower-income countries.